Proactive Investors – The smart money in medicine: the silent pandemic

Proactive Investors – The smart money in medicine: the silent pandemic

Recce Pharmaceuticals is working on a solution.

Recce Pharmaceuticals (ASX:RCE) receives ‘intent to grant’ Patent Family 4 for anti-infectives

Recce Pharmaceuticals (ASX:RCE) receives ‘intent to grant’ Patent Family 4 for anti-infectives

Recce Pharmaceuticals (ASX:RCE) selects CMAX for phase I/II UTI clinical trial

Recce Pharmaceuticals (ASX:RCE) selects CMAX for phase I/II UTI clinical trial

Recce Pharmaceuticals boosts finances with A$6.21 million in R&D rebate payments

Recce Pharmaceuticals boosts finances with A$6.21 million in R&D rebate payments

For this pharma boss, fishing is an experience in positivity

For this pharma boss, fishing is an experience in positivity

Recce Pharmaceuticals (ASX:RCE) granted notification of intent for Australian patent

Recce Pharmaceuticals (ASX:RCE) granted notification of intent for Australian patent